Lexicon Pharmaceuticals
LXRX
#6646
Rank
HK$6.52 B
Marketcap
HK$14.67
Share price
0.54%
Change (1 day)
20.97%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -HK$1.10

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$1.10. In 2025 the company made an earnings per share (EPS) of -HK$1.10 an increase over its 2024 EPS that were of -HK$5.02.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.10-0.22%
2025-HK$1.10-78.13%
2024-HK$5.02-20%
2023-HK$6.2731.15%
2022-HK$4.78-0%
2021-HK$4.7810.91%
2020-HK$4.31-145.08%
2019HK$9.57-206.09%
2018-HK$9.02-5.74%
2017-HK$9.57-10.95%
2016-HK$10.742640%
2015-HK$0.39-96.34%
2014-HK$10.70-2.53%
2013-HK$10.98-9.09%
2012-HK$12.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$148.94-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$46.19-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$368.46-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$40.70 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$20.31-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.88 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-HK$0.71-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$229.72 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA